<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1652446</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case report: Adolescent breast hypertrophy with a tendency toward phyllodes tumor formation: first reported case in China</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liao</surname>
<given-names>Ruiheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3108827/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Yujing</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1765363/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yange</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Plastic and Burn Surgery, West China Hospital of Sichuan University</institution>, <addr-line>Chengdu</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pathology, West China Hospital of Sichuan University</institution>, <addr-line>Chengdu</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2962647/overview">Shuhei Suzuki</ext-link>, Yamagata Prefectural Shinjo Hospital, Japan</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2762858/overview">Andi Muh. Maulana</ext-link>, Universitas Muhammadiyah Purwokerto, Indonesia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3004353/overview">Yosuke Saito</ext-link>, Yamagata University, Japan</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yange Zhang, <email xlink:href="mailto:Zhangyange7801@163.com">Zhangyange7801@163.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1652446</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Liao, Xiao, Chang, Zhang and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liao, Xiao, Chang, Zhang and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Adolescent breast hypertrophy is a rare and persistent condition that affects peripubertal females both physiologically and psychologically. We present a case of a 14-year-old patient with bilateral giant breast enlargement who underwent a successful reduction mammoplasty of 16.5% Body Weight. The right breast exhibited focal interstitial proliferation myofibroblasts, suggesting a potential risk for phyllodes tumor development. This finding represents a novel histopathological association, unreported in the literature and first documented in China.</p>
</abstract>
<kwd-group>
<kwd>adolescent breast hypertrophy</kwd>
<kwd>reduction mammoplasty</kwd>
<kwd>phyllodes tumor</kwd>
<kwd>pathology</kwd>
<kwd>breast tumor</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="26"/>
<page-count count="6"/>
<word-count count="1728"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Breast Cancer</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Adolescent breast hypertrophy, also known as juvenile macromastia or virgin breast hypertrophy, is a benign condition characterized by rapid, disproportionate unilateral or bilateral breast enlargement during puberty (<xref ref-type="bibr" rid="B1">1</xref>). Its precise etiology remains unclear (<xref ref-type="bibr" rid="B2">2</xref>). Hormonal assays are typically unremarkable (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). Early intervention may be beneficial for normal social activities and mental health in adolescence (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). This report describes a case of a 14-year-old Chinese female with adolescent breast hypertrophy who underwent surgical intervention. Notably, postoperative pathology suggested features indicative of phyllodes tumor transformation.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Case report</title>
<p>A 14-year-old female patient presented to our Plastic and Reconstructive Surgery Department with excessive breast volume and ptosis. The patient&#x2019;s height was 155 cm, preoperative weight was 59 kg, and body mass index (BMI) was 24 kg/m&#xb2;. Progressive bilateral breast enlargement over two postpubertal years was accompanied by prominent superficial venous engorgement. The patient&#x2019;s breasts were basically symmetrical on both sides, with the right breast sagging 10 cm below the rib cage and the left sagging 9 cm below the rib cage (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Excessive breast volume precluded accurate volumetric MRI assessment. Preoperatively she underwent a puncture biopsy of the right breast mass, which indicated mesenchymal hyperplasia accompanied by normal-type ductal epithelial hyperplasia. No contributory family history, pharmacotherapy, or gonadotropin axis abnormalities were identified. Breast ultrasonography demonstrated multiple bilateral solid breast lesions suggestive of fibrocystic hyperplasia. Therefore, we can temporarily rule out abnormal breast enlargement caused by endocrine disorders or local breast lesions such as tumors or inflammations.</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Preoperative frontal <bold>(A)</bold> and lateral <bold>(B, C)</bold> views of a patient with adolescent macromastia.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1652446-g001.tif">
<alt-text content-type="machine-generated">Three-panel image showing a person with enlarged breasts. Panel A presents a frontal view; Panel B shows a left side view with a visible dark mark on the arm; Panel C provides a right side view. A blue background is consistent throughout.</alt-text>
</graphic>
</fig>
<p>Given the rapid increase in breast volume and the patient&#x2019;s strong desire for surgical intervention, medical therapy was no longer considered the preferred approach. Furthermore, evidence suggests that in cases involving long pedicles (&gt;10 cm mobilization), large reductions (&gt;2000 g), or severe ptosis, consideration should be given to free nipple&#x2013;areola complex grafting (<xref ref-type="bibr" rid="B8">8</xref>). After thorough preoperative communication with the patient and her family members, the inverted-T incision with inferior pedicle technique and free nipple-areola complex (NAC) graft were ultimately chosen as the operative approach. The distances from the right and left NACs to the inframammary fold (IMF) were 16 cm and 15 cm, respectively. The neo-nipple areolar complex (neo-NAC) on both breasts was positioned 26 cm from the sternal notch. The total amount of breast tissue removed during the operation was 9.6 kg, with 4.7 kg excised from the left side and 4.9 kg from the right (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Histopathological analysis revealed bilateral hyperplasia of interstitial fibrous tissue and myofibroblasts, accompanied by collagenization. The right breast additionally exhibited nuclear fission and pronounced focal hyperplasia of interstitial myofibroblasts, indicating a tendency toward phyllodes formation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Immunohistochemical staining of the right breast lesion showed: Desmin (&#x2013;), SMA (+), CD10 (+), CD34 (+), S-100 (&#x2013;), SOX10 (&#x2013;), EMA (&#x2013;), and Ki67 positivity (10%-15%). Postoperative pathological examination revealed prominent focal interstitial proliferation with mitotic figures. The immunophenotype supported a stromal origin, excluding epithelial or neurogenic lesions. The stroma lacked a typical leaf-like architecture, and based on these findings, the diagnosis was bilateral mammary hypertrophy with a phyllodes-like tendency in the right breast. Given these findings suggesting malignant potential, we recommended close follow-up with biannual postoperative breast imaging (ultrasound and MRI) to monitor recurrence or malignancy.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The illustrations show the breast gland that was preserved during the surgery. (The arrow in the figure indicates the pedicle preserved during surgery).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1652446-g002.tif">
<alt-text content-type="machine-generated">Two-panel image showing a surgical procedure. Panel A depicts a close-up of excised tissue with visible fatty and fibrous structures, marked by arrows. Panel B shows the post-surgical site with sutures securing the skin in place, surrounded by medical drapes.</alt-text>
</graphic>
</fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>[<bold>(A):</bold> H&amp;E,&#xd7;4, <bold>(B):</bold> H&amp;E,&#xd7;10] The bilateral mammary glands were composed of dilated ducts and hyperplastic epithelium. There was a proliferation of interstitial fibrous tissue and myofibroblasts.[<bold>(C):</bold> H&amp;E,&#xd7;40] Myofibroblasts are blazingly proliferative. [<bold>(D):</bold> H&amp;E,&#xd7;40] The interstitium showed prominent mitotic activity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1652446-g003.tif">
<alt-text content-type="machine-generated">Histological images showing four panels labeled A, B, C, and D. Panel A displays a section with scattered glandular structures, indicated by a red arrow. Panel B shows dense connective tissue with fewer glandular structures. Panel C highlights elongated, spindle-shaped cells. Panel D reveals a mix of cells with varied density and a prominent nucleated cell, marked by a red arrow. Each panel includes a micrometer scale for reference.</alt-text>
</graphic>
</fig>
<p>The patient was discharged on postoperative day 7 without medication. At 6-month follow-up, she reported satisfaction with breast aesthetics, and there were no signs of recurrence. (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Postoperative magnetic resonance imaging (MRI) revealed left and right breast volumes of 632 cm&#xb3; and 605 cm&#xb3;, respectively. Bilateral breast ultrasonography revealed no significant abnormalities (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Her emotional state and social participation improved significantly&#x2014;she actively joined the school badminton club, no longer experienced anxiety when choosing clothing, and reported resolution of the sleep disturbance associated with supine positioning prior to surgery. These subjective improvements were consistent with the objective therapeutic outcomes, further supporting the value of breast reduction surgery in adolescent patients with macromastia. Given the patient&#x2019;s adolescent stage, long-term surveillance is recommended every 6&#x2013;12 months thereafter.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Postoperative frontal <bold>(A)</bold> and lateral <bold>(B, C)</bold> views 6 months later.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1652446-g004.tif">
<alt-text content-type="machine-generated">Three-panel image. Panel A shows a front view of a person's chest with visible scars beneath the breasts. Panel B is a side view focusing on the right arm showing a prominent mole. Panel C depicts a side view of the left arm and breast, also showing healed scars. All panels have a blue background.</alt-text>
</graphic>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Overview of the patient treatment process flowchart.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1652446-g005.tif">
<alt-text content-type="machine-generated">Flowchart depicting a medical case progression. Between 2022 and 2024, the patient experienced increased breast volume. In June 2024, they had Doppler ultrasounds and a biopsy. In July 2024, they underwent breast reduction surgery without drug-assisted treatment. In January 2025, a follow-up showed no recurrence.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussion</title>
<p>Adolescent breast hypertrophy is characterized by the excessive development of breast tissue in adolescent females, resulting in disproportionate breast volume relative to torso size (<xref ref-type="bibr" rid="B1">1</xref>). This rapid breast growth can lead to skin stretching, loss of areolar definition, and even ulceration (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Besides the symptoms like back and neck pain, the patient&#x2019;s primary grievances stemmed from social awkwardness and her avoidance of social engagements, which were caused by her exceptionally large breast size. The etiology and pathogenesis of this condition are complex, involving various factors such as hormone levels, genetic predispositions, receptor sensitivity, and environmental influences (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Notably, significant unilateral or bilateral enlargement can occur despite normal gonadal hormone levels, suggesting idiopathic end-organ hypersensitivity&#x2014; manifested as elevated estrogen sensitivity or progesterone receptor upregulation (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). This patient&#x2019;s endocrinology profile were normal, and there was no history of related medication use. The condition may be associated with changes at the genetic or molecular level. Currently, there is no published data clarifying the prevalence of adolescent breast hypertrophy. With the rising health awareness and environmental shifts, more individuals are seeking specialized medical advice and treatment for adolescent breast hypertrophy in hospitals (<xref ref-type="bibr" rid="B15">15</xref>). Therapeutic strategies comprise medical and surgical interventions. Pharmacotherapy (e.g., tamoxifen, bromocriptine) demonstrates limited efficacy in established macromastia but may adjunctively prevent postoperative recurrence (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B17">17</xref>). For this specific patient, given the limited efficacy of pharmacotherapy and the risks associated with adverse drug reactions, surgical treatment alone was sufficient to achieve the therapeutic goals, eliminating the need for additional drug assistance. Since the patient&#x2019;s breast volume was still increasing, the inverted-T incision with inferior pedicle technique and free nipple-areola complex (NAC) graft was ultimately selected to optimize the removal of glandular tissue and minimize the risk of recurrence after surgery, while also considering the shape and volume of the breast. Compared with pedicled reductions, staged procedures, or skin-sparing resections, this technique enables more effective and complete management of enlarged glands within a shorter treatment course, while simultaneously resolving the issues of skin excess and residual hyperplasia (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Besides, Fiumara et&#xa0;al. provided statistical evidence suggesting that the use of free nipple&#x2013;areola complex grafting is associated with a lower recurrence rate compared with the pedicled technique (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>Based on the H&amp;E staining and the immunohistochemical results provided, the pathological examination of this case revealed phyllodes tumor formation predisposition in the right breast. This pathological type has not been reported previously and expands the clinicopathological spectrum of the disease. This type of macromastia indicates that we should consider early assessment, intervention, or surgical treatment. Phyllodes tumors are known for their high recurrence rate. Phyllodes tumors can be classified into three categories: benign, borderline, and malignant. Nuclear division count is one of the core criteria for grading of nodular tumors. Its combined assessment with the Ki-67 index can significantly improve the diagnostic accuracy (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Benign phyllodes tumors are the most common and exhibit histological and clinical features similar to those of fibroadenomas. Higher-grade phyllodes tumors correlate with increased risk of recurrence or metastasis. The similar histologic features of phyllodes tumors and fibroadenomas warrant careful evaluation for the potential progression of fibroadenomas (<xref ref-type="bibr" rid="B23">23</xref>). Currently, the standard treatment for phyllodes tumors involves surgical excision with clear margins, often in conjunction with breast-conserving surgery and is closely monitored during postoperative follow-up (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Adolescent patients face recurrence risks from ongoing breast development or pregnancy-related hormonal shifts (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Consequently, we prioritized reduction mammoplasty as initial therapy, reserving mastectomy for recurrence. There were no signs of recurrence during 6-month follow-up period. The girl was pleased although the aesthetic result was only acceptable from an objective point of view. However, this case also has some limitations, including a relatively short follow-up period and potential diagnostic uncertainties.</p>
</sec>
<sec id="s4" sec-type="conclusions">
<label>4</label>
<title>Conclusion</title>
<p>Surgical intervention remains the primary treatment option for adolescent breast hypertrophy. Medical therapy demonstrates promising potential for disease control and recurrence risk reduction. However, further research is warranted.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the minor(s)&#x2019; legal guardian/next of kin for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>RL: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YX: Writing &#x2013; review &amp; editing. YC: Writing &#x2013; review &amp; editing. ZZ: Data curation, Writing &#x2013; review &amp; editing. YZ: Data curation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are also very thankful for the editors&#x2019; and reviewers&#x2019; valuable suggestions.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuelov</surname> <given-names>R</given-names>
</name>
<name>
<surname>Siplovich</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Juvenile gigantomastia</article-title>. <source>J Pediatr Surg</source>. (<year>1988</year>) <volume>23</volume>:<page-range>1014&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0022-3468(88)80010-1</pub-id>, PMID: <pub-id pub-id-type="pmid">3244074</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kikuchi</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Mustin</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Ghanouni</surname> <given-names>A</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>A review of pediatric macromastia etiology and indications for reduction mammaplasty</article-title>. <source>J Plast Reconstr Aesthet Surg</source>. (<year>2023</year>) <volume>77</volume>:<page-range>209&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bjps.2022.12.003</pub-id>, PMID: <pub-id pub-id-type="pmid">36587475</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kupfer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dingman</surname> <given-names>D</given-names>
</name>
<name>
<surname>Broadbent</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Juvenile breast hypertrophy: report of a familial pattern and review of the literature</article-title>. <source>Plast Reconstr Surg</source>. (<year>1992</year>) <volume>90</volume>:<page-range>303&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00006534-199290020-00023</pub-id>, PMID: <pub-id pub-id-type="pmid">1631223</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Burkey</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>P</given-names>
</name>
<name>
<surname>LaRossa</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Juvenile gigantomastia: presentation of four cases and review of the literature</article-title>. <source>Ann Plast Surg</source>. (<year>2001</year>) <volume>46</volume>:<fpage>517</fpage>&#x2013;<lpage>25; discussion 25-6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00000637-200105000-00011</pub-id>, PMID: <pub-id pub-id-type="pmid">11352426</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karag&#xfc;zel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bilen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kara&#xe7;al</surname> <given-names>N</given-names>
</name>
<name>
<surname>Y&#x131;ld&#x131;z</surname> <given-names>K</given-names>
</name>
<name>
<surname>Livao&#x11f;lu</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Virginal breast hypertrophy: different presentations of 2 cases and the role of tamoxifen as an adjuvant therapy</article-title>. <source>J Pediatr Adolesc Gynecol</source>. (<year>2016</year>) <volume>29</volume>:<page-range>e71&#x2013;e4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpag.2016.03.008</pub-id>, PMID: <pub-id pub-id-type="pmid">27079913</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerrato</surname> <given-names>F</given-names>
</name>
<name>
<surname>Webb</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nuzzi</surname> <given-names>L</given-names>
</name>
<name>
<surname>McCarty</surname> <given-names>ER</given-names>
</name>
<name>
<surname>DiVasta</surname> <given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>The impact of macromastia on adolescents: a cross-sectional study</article-title>. <source>Pediatrics</source>. (<year>2012</year>) <volume>130</volume>:<page-range>e339&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2011-3869</pub-id>, PMID: <pub-id pub-id-type="pmid">22802601</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuzzi</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Firriolo</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Pike</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Cerrato</surname> <given-names>FE</given-names>
</name>
<name>
<surname>Webb</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Faulkner</surname> <given-names>HR</given-names>
</name>
<etal/>
</person-group>. <article-title>The effect of reduction mammaplasty on quality of life in adolescents with macromastia</article-title>. <source>Pediatrics</source>. (<year>2017</year>) <volume>140</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2017-1103</pub-id>, PMID: <pub-id pub-id-type="pmid">28986442</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rancati</surname> <given-names>A</given-names>
</name>
<name>
<surname>Irigo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Angrigiani</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Management of the ischemic nipple-areola complex after breast reduction</article-title>. <source>Clinics Plast Surg</source>. (<year>2016</year>) <volume>43</volume>:<page-range>403&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cps.2015.12.011</pub-id>, PMID: <pub-id pub-id-type="pmid">27012799</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentimi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Loupatatzi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Euthimoglou</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Michailidou</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Tzovaras</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Kaja</surname> <given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>Juvenile gigantomastia in a 12-year-old girl: a case report</article-title>. <source>Aesthetic Plast Surg</source>. (<year>2011</year>) <volume>35</volume>:<page-range>414&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00266-010-9597-4</pub-id>, PMID: <pub-id pub-id-type="pmid">20927517</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pokhrel</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gautam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pokhrel</surname> <given-names>NB</given-names>
</name>
<name>
<surname>Bhatta</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Rayamajhi</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Virginal breast hypertrophy in a 14-year-old girl: A case report</article-title>. <source>Clin Case Rep</source>. (<year>2021</year>) <volume>9</volume>:<fpage>198</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ccr3.3498</pub-id>, PMID: <pub-id pub-id-type="pmid">33489159</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lozito</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gemelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Micello</surname> <given-names>D</given-names>
</name>
<name>
<surname>Vinci</surname> <given-names>V</given-names>
</name>
<name>
<surname>Pelosi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ricotta</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Immune-related gigantomastia: a case study</article-title>. <source>Immunotherapy</source>. (<year>2023</year>) <volume>15</volume>:<page-range>1001&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.2217/imt-2023-0056</pub-id>, PMID: <pub-id pub-id-type="pmid">37431623</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yokogawa</surname> <given-names>N</given-names>
</name>
<name>
<surname>Higuchi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tsujino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shimada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sugii</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Bucillamine-induced gigantomastia with galactorrhea and hyperprolactinaemia</article-title>. <source>Mod Rheumatol Case Rep</source>. (<year>2020</year>) <volume>4</volume>:<page-range>122&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/24725625.2019.1673939</pub-id>, PMID: <pub-id pub-id-type="pmid">33086961</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govrin-Yehudain</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kogan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>HI</given-names>
</name>
<name>
<surname>Falik-Zaccai</surname> <given-names>TC</given-names>
</name>
</person-group>. <article-title>Familial juvenile hypertrophy of the breast</article-title>. <source>J Adolesc Health</source>. (<year>2004</year>) <volume>35</volume>:<page-range>151&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jadohealth.2003.09.017</pub-id>, PMID: <pub-id pub-id-type="pmid">15261644</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Systemic deficiency of PTEN accelerates breast cancer growth and metastasis</article-title>. <source>Front Oncol</source>. (<year>2022</year>) <volume>12</volume>:<elocation-id>825484</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2022.825484</pub-id>, PMID: <pub-id pub-id-type="pmid">35372075</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasielska-Trojan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Danilewicz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stru&#x17c;yna</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bugaj</surname> <given-names>M</given-names>
</name>
<name>
<surname>Antoszewski</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>The role of oestrogen and progesterone receptors in gigantomastia</article-title>. <source>Arch Med Sci</source>. (<year>2019</year>) <volume>18</volume>:<page-range>1016&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.5114/aoms.2019.88280</pub-id>, PMID: <pub-id pub-id-type="pmid">35832720</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santen</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Karaguzel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Livaoglu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cline</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Ratan</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of ER&#x3b1; and aromatase in juvenile gigantomastia</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2024</year>) <volume>109</volume>:<page-range>1765&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/clinem/dgae019</pub-id>, PMID: <pub-id pub-id-type="pmid">38227777</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alhindi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mortada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Alzaid</surname> <given-names>W</given-names>
</name>
<name>
<surname>Al Qurashi</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Awan</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>A systematic literature review of the clinical presentation, management, and outcome of gestational gigantomastia in the 21st century</article-title>. <source>Aesthetic Plast Surg</source>. (<year>2023</year>) <volume>47</volume>:<fpage>10</fpage>&#x2013;<lpage>29</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00266-022-03003-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35941388</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi de Aguiar</surname> <given-names>B</given-names>
</name>
<name>
<surname>Santos Silva</surname> <given-names>R</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Castro-Correia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fontoura</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Juvenile breast hypertrophy</article-title>. <source>Endokrynol Polska</source>. (<year>2020</year>) <volume>71</volume>:<page-range>202&#x2013;3</page-range>. doi: <pub-id pub-id-type="doi">10.5603/EP.a2019.0063</pub-id>, PMID: <pub-id pub-id-type="pmid">31909454</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mareti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Vatopoulou</surname> <given-names>A</given-names>
</name>
<name>
<surname>Spyropoulou</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Papanastasiou</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pratilas</surname> <given-names>GC</given-names>
</name>
<name>
<surname>Liberis</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Breast disorders in adolescence: A review of the literature</article-title>. <source>Breast Care (Basel Switzerland)</source>. (<year>2021</year>) <volume>16</volume>:<page-range>149&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000511924</pub-id>, PMID: <pub-id pub-id-type="pmid">34012369</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiumara</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gault</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Nel</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Lucas</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Courtauld</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Massive bilateral breast reduction in an 11-year-old girl: 24% ablation of body weight</article-title>. <source>J Plastic Reconstruct Aesthetic Surg: JPRAS</source>. (<year>2009</year>) <volume>62</volume>:<page-range>e263&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bjps.2007.10.053</pub-id>, PMID: <pub-id pub-id-type="pmid">18291739</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>TTA</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nayak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Duckworth</surname> <given-names>LA</given-names>
</name>
<etal/>
</person-group>. <article-title>Validation study of the newly proposed refined diagnostic criteria for Malignant phyllodes tumor with 136 borderline and Malignant phyllodes tumor cases</article-title>. <source>Am J Surg Pathol</source>. (<year>2024</year>) <volume>48</volume>:<page-range>1146&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PAS.0000000000002264</pub-id>, PMID: <pub-id pub-id-type="pmid">38934254</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Tam</surname> <given-names>KW</given-names>
</name>
</person-group>. <article-title>Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence</article-title>. <source>Int J Surg (London England)</source>. (<year>2022</year>) <volume>107</volume>:<fpage>106969</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijsu.2022.106969</pub-id>, PMID: <pub-id pub-id-type="pmid">36328344</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ong</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Thike</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>LM</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic landscapes of breast fibroepithelial tumors</article-title>. <source>Nat Genet</source>. (<year>2015</year>) <volume>47</volume>:<page-range>1341&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng.3409</pub-id>, PMID: <pub-id pub-id-type="pmid">26437033</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lissidini</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mul&#xe8;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Santoro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Papa</surname> <given-names>G</given-names>
</name>
<name>
<surname>Nicosia</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cassano</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Malignant phyllodes tumor of the breast: a systematic review</article-title>. <source>Pathologica</source>. (<year>2022</year>) <volume>114</volume>:<page-range>111&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.32074/1591-951X-754</pub-id>, PMID: <pub-id pub-id-type="pmid">35414723</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudson</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Morzycki</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Guilfoyle</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Reduction mammaplasty for macromastia in adolescents: A systematic review and pooled analysis</article-title>. <source>Plast Reconstr Surg</source>. (<year>2021</year>) <volume>148</volume>:<fpage>31</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PRS.0000000000008102</pub-id>, PMID: <pub-id pub-id-type="pmid">34181602</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuzzi</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Pramanick</surname> <given-names>T</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Firriolo</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Massey</surname> <given-names>GG</given-names>
</name>
<name>
<surname>DiVasta</surname> <given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>Optimal timing for reduction mammaplasty in adolescents</article-title>. <source>Plast Reconstr Surg</source>. (<year>2020</year>) <volume>146</volume>:<page-range>1213&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PRS.0000000000007325</pub-id>, PMID: <pub-id pub-id-type="pmid">33234945</pub-id></citation></ref>
</ref-list>
</back>
</article>